HomeQuestion
Will you offer capecitabine for 1 year to all localized TNBC patients?
3
1 Answers
Mednet Member
Medical Oncology · H Lee Moffitt Cancer Center, University of South Florida
The SYSUCC trial enrolled stage Ib-III TNBC patients who had either neoadjuvant or adjuvant systemic treatment followed by standard local therapy, and randomized the patients to either get 1 year of metronomic dosed capecitabine (650mg/m2 BID no break) x 12 months or observation. They observed an im...